NYSEMKT:MYO

Myomo Stock Insider Trading

Healthcare > Medical - Devices

Buy MYO

*Your capital is at risk

$1.10

-0.0600 (-5.17%)

At Close: Jul 10, 2026

Myomo Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 27.70. In total, the insiders bought 2.64M and sold 652.93K MYO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	27.70
● Buy	2.64M shares
● Sell	652.93K shares
68% Buy Activity Strong Negative Correlation
Buy Signal Medium Confidence Jun 25, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 27.7. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 25, 2026 Buy	Common Stock A-Award	Morris Milton Mayo Director	Director	78 704 Value: $85.0K
Jun 25, 2026 Buy	Common Stock A-Award	Getz Heather C Director	Director	78 704 Value: $85.0K
Jun 25, 2026 Buy	Common Stock A-Award	Kirk Thomas F Director	Director	78 704 Value: $85.0K
Jun 25, 2026 Buy	Common Stock A-Award	Manko Joseph M. Jr. Director	Director	78 704 Value: $85.0K
Jun 25, 2026 Buy	Common Stock A-Award	Crowley Thomas Aloysius Jr. Director	Director	78 704 Value: $85.0K
Jun 25, 2026 Buy	Common Stock A-Award	Febbo William J Director	Director	78 704 Value: $85.0K
Jun 12, 2026 Sell	Common Stock F-InKind	Mitchell Micah Chief Commercial Officer	Officer	9 061 Value: $10.9K
Jun 12, 2026 Sell	Common Stock F-InKind	Kovelman Harry Chief Medical Officer	Officer	10 442 Value: $12.5K
Jun 12, 2026 Sell	Common Stock F-InKind	Henry David A Chief Financial Officer	C-Suite Officer	10 969 Value: $0
Jun 08, 2026 Sell	Common Stock F-InKind	Kovelman Harry Chief Medical Officer	Officer	7 635 Value: $10.2K
Jun 08, 2026 Sell	Common Stock F-InKind	Mitchell Micah Chief Commercial Officer	Officer	6 529 Value: $9K
Jun 08, 2026 Sell	Common Stock F-InKind	Henry David A Chief Financial Officer	C-Suite Officer	10 050 Value: $0
Jun 05, 2026 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	40 002 Value: $50.8K
May 28, 2026 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	25 000 Value: $24.8K
May 28, 2026 Sell	Common Stock S-Sale	Kovelman Harry Chief Medical Officer	Officer	11 536 Value: $11.7K
May 27, 2026 Sell	Common Stock S-Sale	Kovelman Harry Chief Medical Officer	Officer	20 464 Value: $20.5K
May 18, 2026 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	43 401 Value: $39.5K
May 15, 2026 Buy	MYO P-Purchase	Manko Joseph M. Jr. Director	Director	30 367 Value: $27.0K
May 15, 2026 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	31 605 Value: $28.7K
May 14, 2026 Sell	Common Stock S-Sale	Mitchell Micah Chief Commercial Officer	Officer	90 231 Value: $77.7K
May 14, 2026 Buy	MYO P-Purchase	Manko Joseph M. Jr. Director	Director	170 830 Value: $146.9K
May 09, 2026 Buy	MYO	Manko Joseph M. Jr. Director	Director	0 Value: $0
Apr 14, 2026 Buy	Common Stock J-Other	Febbo William J Insider	Other	0 Value: $0
Apr 14, 2026 Buy	Common Stock A-Award	Febbo William J Director	Director	45 000 Value: $35.6K
Apr 13, 2026 Sell	Common Stock F-InKind	Henry David A Chief Financial Officer	C-Suite Officer	3 953 Value: $3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MYOMO, INC

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents wit...

Read Full Profile Here